As we've highlighted, the dangerous effort to weaken critical patent protections for U.S. pharmaceutical…
CFIF on Twitter CFIF on YouTube
Image of the Day: Private Sector Pharmaceutical Investment Propels Innovation

As we've highlighted, the dangerous effort to weaken critical patent protections for U.S. pharmaceutical innovators often minimizes the role of private investment and exaggerates the role of public funding.  This offers a critical corrective at a moment when American drug and vaccine innovation is more important than ever:

[caption id="" align="aligncenter" width="530"] The Critical Role of Private Pharmaceutical Investment[/caption]…[more]

May 14, 2021 • 09:16 AM

Liberty Update

CFIFs latest news, commentary and alerts delivered to your inbox.
Home Press Room CFIF Submits Formal Comment on NIST Proposed Rule Regarding Bayh-Dole Act of 1980
CFIF Submits Formal Comment on NIST Proposed Rule Regarding Bayh-Dole Act of 1980 Print
Monday, April 12 2021

Last week, the Center for Indvidiual Freedom (CFIF) submitted a formal Comment with the U.S. Commerce Department's National Institute of Standards and Technology (NIST) on its Proposed Rule regarding the Bayh-Dole Act of 1980, which granted universities, nonprofit organizations and small business the right to patent and license inventions funded partly by federal funding. 

The Economist magazine called the Bayh-Dole Act "Possibly the most inspired piece of legislation to be enacted in America over the past half century," and rightfully so.   It unleashed a tidal wave of hundreds of thousands of patents issued to American universities and research institutes since then. 

On that basis, CFIF supports the Proposed Rule to the extent that it advances the provisions and intent of Bayh-Dole, with the caveat that insertion of the terms "exclusively" and "of the contractor" in the Proposed Rule's text may open the door for advocates of drug price controls to suggest that business decisions of pharmaceutical innovators regarding the pricing of commercial goods and services arising from the practical application of inventions may serve as one basis for exercising march-in rights.  Neither the text nor the intent of the Bayh-Dole Act allow that, as namesake Senators Bayh and Dole themselves pointed out in a joint statement to The Washington Post

On that basis we urge that the Proposed Rule omit those terms.  We must ensure that Bayh-Dole's four-decade legacy of incredible success continues, without the looming threat that activists may attempt to use it to impose destructive drug price controls on American consumers.

Read CFIF's comment here (PDF).

Related Articles :
Quiz Question   
What was the last year in which gold was used as the basis for valuing the U.S. dollar?
More Questions
Notable Quote   
 
"My colleague Casey Mulligan of the University of Chicago and I predicted in the Wall Street Journal three months ago that the $300 per week extra unemployment benefits would mean 5 to 6 million people not going back to work because the government was paying them more not to work. The Left laughed at this prediction. Now, we see record jobs going unfilled, 8.1 million, even when there are 9 million…[more]
 
 
—Stephen Moore, Co-Founder of the Committee to Unleash Prosperity and Former Member of President Trump’s Economic Recovery Task Force
— Stephen Moore, Co-Founder of the Committee to Unleash Prosperity and Former Member of President Trump’s Economic Recovery Task Force
 
Liberty Poll   

Which one of the following do you view as the greatest threat to the U.S. economy as we recover from the coronavirus disruption?